Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cancer Care Management During the Covid-19 Pandemic Publisher



Jafari A1 ; Rezaeitavirani M1 ; Karami S3 ; Yazdani M4 ; Zali H1, 5 ; Jafari Z6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
  5. 5. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. 9Dey Manzariye Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Risk Management and Healthcare Policy Published:2020


Abstract

New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of such patients. During the COVID-19 pandemic, it is important to provide strategies for managing the treatment of patients with cancer to limit COVID-19-associated risks at this difficult time. The present study set out to summarize the latest research on epidemiology, pathogenesis, and clinical features of COVID-19. We also address some of the current challenges associated with the management of patients with cancer during the COVID-19 pandemic and provide practical guidance to clinically deal with these challenges. © 2020 Jafari et al.
Other Related Docs
10. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
11. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
13. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
15. A Narrative Review of Covid-19: The New Pandemic Disease, Iranian Journal of Medical Sciences (2020)
18. Clinical Characteristics of Covid-19-Infected Cancer Patients, Isfahan, Iran, Journal of Research in Medical Sciences (2022)
20. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
21. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
23. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)
27. Cytokines and Micrornas in Sars-Cov-2: What Do We Know?, Molecular Therapy Nucleic Acids (2022)
29. Clinical Display, Diagnostics and Genetic Implication of Novel Coronavirus (Covid-19) Epidemic, European Review for Medical and Pharmacological Sciences (2020)
35. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
42. A Late Covid-19 Complication: Male Sexual Dysfunction, Prehospital and Disaster Medicine (2020)
43. Covid19 Prevention & Care; a Cancer Specific Guideline, Archives of Iranian Medicine (2020)
49. Hepatic Disorders and Covid-19: From Pathophysiology to Treatment Strategy, Canadian Journal of Gastroenterology and Hepatology (2022)